%0 Journal Article
%T Management of soft tissue sarcomas of the chest wall: a comprehensive overview.
%A van Roozendaal LM
%A Bosmans JWAM
%A Daemen JHT
%A Franssen AJPM
%A van Bastelaar J
%A Engelen SME
%A Keymeulen KBMI
%A Aguiar WWS
%A de Campos JRM
%A Hulsewé KWE
%A Vissers YLJ
%A de Loos ER
%J J Thorac Dis
%V 16
%N 5
%D 2024 May 31
%M 38883634
%F 3.005
%R 10.21037/jtd-23-1149
%X Sarcomas of the chest wall are rare and their current treatment regimen is diverse and complex due to the heterogeneity of these tumors as well as the variations in tumor location and extent. They only account for 0.04% of newly diagnosed cancers of whom about 45% comprise soft tissue sarcomas. Larger cohort studies are scarce and often focus on one specific treatment item. We therefore aim to provide helicopter view for clinicians treating patients with sarcomas of the chest wall, focusing mainly on soft tissue sarcomas. This overview includes the value of neoadjuvant systemic or radiotherapy, surgical resection, approaches for thoracic wall reconstruction, and the need for follow-up. Provided the heterogeneity and relative rarity, we recommend that treatment decisions in soft tissue sarcoma of the chest wall are discussed in a multidisciplinary tumor board at a reference sarcoma center or within sarcoma networks to ensure personalized, rational decision making. A surgical oncologist specialized in sarcoma surgery is crucial, and for extensive resections involving the thoracic cavity we recommend involvement of a thoracic surgeon. In addition, a specialized medical- and radiation oncologist as well as a plastic surgeon is required to ensure the best multimodality treatment plan to optimize patient outcome.